Results 31 to 40 of about 262,287 (292)

Duloxetine in the treatment of generalized anxiety disorder

International Journal of General Medicine, 2009
Alan Wright, Chad VanDenBergCenter for Clinical Research, Mercer University, Atlanta, GA, USAAbstract: Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) which is FDA approved for the treatment of generalized anxiety disorder (GAD) in ...
Alan Wright, Chad VanDenBerg
doaj   +2 more sources

Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders [PDF]

, 2018
OBJECTIVE: This study aimed to examine whether the Unified Protocol (UP), a transdiagnostic cognitive-behavioral therapy for emotional disorders (i.e., anxiety, mood, and related disorders), is efficacious in the treatment of co-occurring emotional ...
Ametaj, Amanda, Barlow, David H., Cassiello-Robbins, Clair, Farchione, Todd J., Sauer-Zavala, Shannon, Sbi, Sophia, Steele, Stephanie Jarvi   +6 more
core   +2 more sources

Acceptability and proof of concept of internet-delivered treatment for depression, anxiety, and stress in university students: protocol for an open feasibility trial [PDF]

, 2016
BACKGROUND: In recent years, university counseling and mental health services have reported an increase in the number of clients seeking services and in yearly visits.
Beidel, Deborah, Bonner, Christopher, Frazier, Patricia, Hofmann, Stefan G., Mooney, Jacqueline, Palmieri, Patrick A., Richards, Derek   +6 more
core   +1 more source

Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Parents of children treated for acute lymphoblastic leukemia (ALL) often experience significant caregiver burden and disruption to their well‐being. While parent quality of life (QoL) during treatment is well characterized, little is known about outcomes during early survivorship.
Sara Dal Pra, Maria McCarthy, Michael Takagi, Cinzia De Luca   +3 more
wiley   +1 more source

Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM1

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView., 2023
Abstract Dynamin 1 is a GTPase protein involved in synaptic vesicle fission, which facilitates the exocytosis of neurotransmitters necessary for normal signaling. Pathogenic variants in the DNM1 gene are associated with intractable epilepsy, often manifested as infantile spasms at onset, developmental delay, and a movement disorder, and are located in ...
Davide Mei, Elena Parrini, Claudia Bianchini, Maria Luisa Ricci, Renzo Guerrini   +4 more
wiley   +1 more source

Serum oxytocin levels in patients with depression, social anxiety disorder, generalized anxiety disorder, and panic disorder diagnosed according to DSM-5 criteria compared with healthy controls

Psychiatry and Clinical Psychopharmacology, 2021
OBJECTIVE: Oxytocin is a hormone which effects are well known on birth, breastfeeding, and bonding between mother and child and couples. In addition, oxytocin is called endogenous anti-stress, antidepressants, and anxiolytic hormone and reported that it
Taha Can Tuman, Osman Yildirim, Abdulbaki Irmak, Ali Evren Tufan, Mehmet Akif Camkurt   +4 more
doaj  

Effect of an Integrated Cognitive-Behavioral, Acceptance, and Commitment Intervention on Generalized Anxiety Disorder among University Students [PDF]

Journal of Education and Community Health, 2018
Background and Objective: Regarding the importance of generalized anxiety disorder, this study aimed to investigate the effect of an integrated cognitive-behavioral, acceptance, and commitment intervention on generalized anxiety disorder among students ...
Alireza Zolfaghari , Hadi Bahrami , Kamran Ganji   +2 more
doaj   +1 more source

A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators [PDF]

, 2017
INTRODUCTION: Social anxiety disorder (SAD) is among the most prevalent mental disorders, associated with impaired functioning and poor quality of life. Pharmacotherapy is the most widely utilized treatment option.
Borenstein M, Hofmann SG, Jasper Smits, Joshua Curtiss, Leigh Andrews, Lipsey MW, Michelle Davis, Stefan G. Hofmann, Stein MB   +8 more
core   +2 more sources

Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein, Haoqi Sun, Sophie Lehnerer, Lea Gerischer, Maximilian Mönch, Christian Meisel, Andreas Meisel, Pushpa Narayanaswami   +7 more
wiley   +1 more source

Altered levels of malondialdehyde and vitamin E in major depressive disorder and generalized anxiety disorder [PDF]

Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2012
Introduction: Reactive oxygen species (ROS) may play a role in some neuropsychiatric disorders. There is some evidence that the activation of immune-inflammatory processes, an increase in monoamines catabolism and abnormalities in lipid compounds may ...
kemal yazici, aylin yazici, şenel tot acar, nilgun bal, lulufer tamer   +4 more
doaj